Immune epitope and analysis program

Ended Definitive Contract Awarded Last action

Contract number
75N93019C00001
Awardee
Awarding agency
Obligated
$24,260,098

Award facts

Opportunity
Contract value 65% obligated
  • $24,260,098.03 Current, with exercised options
  • $37,249,201.01 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
La Jolla, CA 92037, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00019 · Immune epitope and analysis program (iedb) $699,999
Funding Only Action P00018 -$13,081
Exercise an Option P00017 $3,340,828
Change Order P00016 $500,000
Exercise an Option P00015 $3,234,837
Exercise an Option P00014 $3,209,450
Other Administrative Action P00012 $0
Other Administrative Action P00013 $0
Exercise an Option P00011 $3,440,531
Other Administrative Action P00010 $0
Change Order P00009 $199,257
Exercise an Option P00008 $3,003,484
Change Order P00007 $338,969
Change Order P00006 $163,763
Other Administrative Action P00005 $0
Vendor DUNS or Name Change - Non-Novation P00004 $0
Exercise an Option P00003 $2,937,230
Other Administrative Action P00002 $0
Exercise an Option P00001 $34,999
Original award $3,169,832
Show all 20

About this award

Written by GovTribe AI ·

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $37.25 million Cost-No-Fee definitive contract to the La Jolla Institute for Immunology (LJI) for continuation of the Immune Epitope and Analysis Program (IEDB). This contract, which runs through March 2026, supports LJI's mission to maintain and enhance a comprehensive database and analysis resource for immune epitope research. The IEDB serves as a critical scientific resource for the immunological research community, enabling researchers to access curated data on immune responses to infectious pathogens, allergens, and other antigens. No socioeconomic set-aside was applied to this award, reflecting open competition based on technical merit.

The contract work is supported by a well-established team of subcontractors providing specialized expertise across database management, bioinformatics, and immunological tools. Leidos, Inc. (operating as SAIC) maintains and optimizes the IEDB database system and web portal, manages curation workflows, and develops web-based interfaces for data access and submission. Danmarks Tekniske Universitet (Technical University of Denmark) maintains and develops epitope prediction tools, including MHC binding prediction models, T-cell receptor-based prediction tools, and B-cell epitope analysis capabilities. Yale University's recent subcontract contribution involves developing common data elements to standardize the description of biological samples used in immune profiling studies. Together, these partners ensure the IEDB remains a current, functional resource supporting immunological research relevant to vaccine development, infectious disease understanding, and immune response characterization.

Subawards

Subcontractor Amount Awarded
Yale Univ IMMUNE EPITOPE AND ANALYSIS PROGRAM The work at Yale involves the development of a set of Common Data Elements (CDEs) to describe biological samples used as… $170,000
Danmarks Tekniske Universitet IMMUNE EPITOPE AND ANALYSIS PROGRAM The primary responsibilities of DTU as part of IEDB & AR program are to maintain, enhance and update the existing set of… $341,580
Leidos, Inc. IMMUNE EPITOPE AND ANALYSIS PROGRAM The primary responsibility of Leidos as part of the IEDB & AR program is to maintain and improve the existing IEDB… $496,274
Danmarks Tekniske Universitet IMMUNE EPITOPE AND ANALYSIS PROGRAM The primary responsibilities of DTU as part of IEDB & AR program are to maintain, enhance and update the existing set of… $331,602

Quick answers

Who was awarded contract 75N93019C00001?

75N93019C00001 was awarded to La Jolla Institute For Immunology by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2018.

How much is contract 75N93019C00001 worth?

The government has obligated $24,260,098 on 75N93019C00001. Its potential value, with all options, is $37,249,201.

Was contract 75N93019C00001 competed?

The extent of competition for 75N93019C00001 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login